Chen Kuo-Hsin, Siow Tiing Foong, Chio U-Chon, Wu Jiann-Ming, Jeng Kuo-Shyang
Division of General Surgery, Department of Surgery, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
Division of Electrical Engineering, Yuan Ze University, Taoyuan, Taiwan.
Asian J Endosc Surg. 2018 May;11(2):112-117. doi: 10.1111/ases.12606.
Laparoscopic liver resection has been applied to treat most indications for liver resection during the past two decades. According to the literature, patient numbers have increased exponentially as a result, and surgical difficulty has increased as well. In expert centers, laparoscopic anatomical hemihepatectomy and major liver resection more than 3 segments have become the acceptable treatment. Moreover, with surgical innovations and accumulated experience, living donor liver transplantation has become an established treatment choice for patients on the transplant waiting list. It is even considered an inevitable choice in regions with limited access to organs from deceased donors. However, significant morbidity and rare but catastrophic mortality are associated with donor hepatectomy and remain major concerns. Therefore, to decrease the incidence of complications, a minimally invasive approach in donor hepatectomy was adopted in the early 2000s. Initially, a minimally invasive approach was used for left lateral sectionectomy for pediatric liver transplant, then for laparoscopy-assisted hemihepatectomy and pure laparoscopic/robotic right donor hepatectomy, and more recently, for adult living donor liver transplantation. The extent of procedure complexity and potential complications depends on the approach and the size of the graft to be harvested. Early results from expert teams have seemed promising in terms of shortened donor recovery and improved perioperative outcomes. However, the combination of these two highly sophisticated surgical procedures raise more concerns about donor safety, especially with regard to unexpected events during the operation. A high level of evidence is very difficult to achieve in this highly specialized surgical practice with limited penetration. Therefore, an international registry has been suggested to determine the risks and benefits before the use of laparoscopic right donor hepatectomy spreads.
在过去二十年中,腹腔镜肝切除术已被应用于治疗大多数肝切除适应症。根据文献记载,其结果是患者数量呈指数级增长,手术难度也有所增加。在专家中心,腹腔镜解剖性半肝切除术和超过3个肝段的肝大部切除术已成为可接受的治疗方法。此外,随着手术创新和经验积累,活体肝移植已成为移植等待名单上患者的既定治疗选择。在已故供体器官获取受限的地区,它甚至被视为必然选择。然而,供肝切除术伴有显著发病率以及罕见但灾难性的死亡率,仍然是主要关注点。因此,为降低并发症发生率,21世纪初在供肝切除术中采用了微创方法。最初,微创方法用于小儿肝移植的左外侧段切除术,随后用于腹腔镜辅助半肝切除术和单纯腹腔镜/机器人右供肝切除术最近则用于成人活体肝移植。手术复杂程度和潜在并发症的程度取决于手术方式以及要获取的移植物大小。专家团队早期的结果在缩短供体恢复时间和改善围手术期结局方面似乎很有前景。然而这两种高度复杂的手术相结合引发了更多关于供体安全的担忧,尤其是手术期间发生意外事件时。在这种渗透率有限的高度专业化外科实践中很难获得高水平证据。因此有人建议设立一个国际登记处,以便在腹腔镜右供肝切除术广泛应用之前确定其风险和益处